Study of Disrupted Sleep in Somali Americans
Mayo Clinic · with National Heart, Lung, and Blood Institute (NHLBI) · NCT05411029
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–70 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 240
- US sites recruiting
- 1
- Study start
- November 15, 2022
- Record last updated
- September 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The aims of this study are to determine the types and severity of previously undiagnosed sleep deficiencies in otherwise healthy Somali Americans, apply a research framework to define psychosocial, behavioral, environmental, and biological mechanisms mediating sleep deficiencies in Somali Americans, and examine the relationship between sleep deficiencies and increased blood pressure in Somali Americans.
Being studied: 24 hour blood pressure (BP) monitoring; Polysomnography
Conditions: Hypertension; Sleep Disorder; Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Subjects diagnosed with no known history of hypertension, diabetes, or sleep disorders.
- Self-identify as Somali.
- Adult males and females who are older than 18 years of age.
Exclusion Criteria
- Anyone under 18 years or over 70 years.
- Positive pregnancy.
Recruiting US locations
Mayo Clinic in Rochester
Rochester, MN 55905
Site contact: Virend Somers, MD
Study contacts (from the official record)
- Somers CPL Lab · 507-422-3499 · CPLSOMALI@mayo.edu
Similar studies in Minnesota
All sleep studies in Minnesota →- RecruitingHealthy volunteersOvernight stay mentioned
Circadian Rhythms in Human Adipose
Mayo Clinic
- Location
- Rochester, MN
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
Pfizer
- Location
- Maplewood, MN + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
- Location
- Maplewood, MN + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Alkermes, Inc.
- Location
- Rochester, MN + 21 other US sites
- Eligibility basics
- Ages 18–70